Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000171.xml
Dtsch Med Wochenschr 2011; 136(22): 1187-1190
DOI: 10.1055/s-0031-1280537
DOI: 10.1055/s-0031-1280537
Nephrologie | Commentary
Nephrologie, Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York
Primäre und sekundäre (renovaskuläre) arterielle Hypertonie
Primary and secondary (renovascular) arterial hypertensionFurther Information
Publication History
Publication Date:
24 May 2011 (online)
![](https://www.thieme-connect.de/media/dmw/201122/lookinside/thumbnails/10.1055-s-0031-1280537-1.jpg)
Schlüsselwörter
Hypertonie - Blutdruckziele - Nierenarterienstenose
Keywords
hypertension - blood pressure targets - renal artery stenosis
Literatur
- 1 The ACCORD Study Group . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362 1575-1585
- 2 ADVANCE Collaborative Group . Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007; 370 829-840
- 3 The ARB Trialists Collaboration . Effects of telmisartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals. J Hypertension. 2011; 29 623-635
- 4 Appel L J, Wright J T, Greene T. et al . Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010; 363 918-929
- 5 The Astral Investigators . Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009; 361 1953-1962
- 6 Bax L, Woittiez A J, Kouwenberg H J. et al . Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009; 150 840-848
- 7 The ESCAPE Trial Group . Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009; 361 1639-1650
- 8 Julius S, Kjeldsen S E, Weber M A. et al . Angiotensin-receptor blockade, cancer, and concerns. Lancet Oncol. 2010; 11 820-821
- 9 Krum H, Schlaich M, Whitbourn R. et al . Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009; 373 1275-1281
- 10 Peterson J C, Adler S, Burkart J M. et al . Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med. 1995; 123 754-762
- 11 Sandset E C, Bath P MW, Boysen G. et al . The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial. Lancet. 2011; 377 741-750
- 12 Sarnak M J, Greene T, Wang X. et al . The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study. Ann Intern Med. 2005; 142 342-351
- 13 Sipahi I, Debanne S M, Rowland D Y. et al . Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. Lancet Oncol. 2010; 11 627-636
- 14 Symplicity HTN-2 Investigators . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010; 376 1903-1909
- 15 Trinquart L, Mounier-Vehier C, Sapoval M. et al . Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010; 56 525-532
Prof. Dr. Martin Hausberg
Medizinische Klinik I mit Schwerpunkt Allgemeine
Innere
Medizin, Nephrologie, Rheumatologie und Pneumologie
Städtisches
Klinikum Karlsruhe
76133 Karlsruhe
Email: martin.hausberg@klinikum-karlsruhe.de
Prof. Dr. Bernhard Krämer
V. Medizinische Klinik
Universitätsmedizin
Mannheim
Theodor-Kutzer-Ufer 1–3
68167 Mannheim
Email: bernhard.kraemer@umm.de